These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 8482311

  • 1. Effects of PGE1 in experimental vasoconstrictive pulmonary hypertension.
    Dagher E, Dumont L, Chartrand C, Blaise G.
    Eur Surg Res; 1993; 25(2):65-73. PubMed ID: 8482311
    [Abstract] [Full Text] [Related]

  • 2. Effects of amrinone and dobutamine on PGF2 alpha-induced pulmonary hypertension in dogs.
    Dumont L, Dagher E.
    Eur Surg Res; 1994; 26(4):201-9. PubMed ID: 7957456
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy of inhaled prostanoids in experimental pulmonary hypertension.
    Kleen M, Habler O, Hofstetter C, Pusch R, Mueller M, Welte M, Zwissler B.
    Crit Care Med; 1998 Jun; 26(6):1103-9. PubMed ID: 9635662
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy of right atrial infusion of PGE1 in sepsis-induced pulmonary hypertension.
    Marini CP, Woloszyn T, Coons M, Tachmes L, Nathan I, Cunningham JN, Jacobowitz IJ.
    J Surg Res; 1990 Dec; 49(6):476-82. PubMed ID: 2124641
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prostaglandin E1 antagonizes hypoxic pulmonary vasoconstriction but reduces systemic blood pressure in dogs.
    Ishibe Y, Shiokawa Y, Umeda T, Uno H, Nakamura M, Izumi T.
    Crit Care Med; 1998 Jan; 26(1):126-31. PubMed ID: 9428554
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Successful weaning from cardiopulmonary bypass with central venous prostaglandin E1 and left atrial norepinephrine infusion in patients with acute pulmonary hypertension.
    Tritapepe L, Voci P, Cogliati AA, Pasotti E, Papalia U, Menichetti A.
    Crit Care Med; 1999 Oct; 27(10):2180-3. PubMed ID: 10548203
    [Abstract] [Full Text] [Related]

  • 13. Pulmonary vascular effects of hydralazine in a canine preparation of pulmonary thromboembolism.
    Ducas J, Girling L, Schick U, Prewitt RM.
    Circulation; 1986 May; 73(5):1050-7. PubMed ID: 3698227
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Hemodynamic effects of prostaglandin E1 in patients with congenital heart disease and pulmonary hypertension].
    Pan S, Xiao M, Liu Y.
    Zhonghua Wai Ke Za Zhi; 1996 May; 34(5):276-9. PubMed ID: 9387702
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hemodynamic profiles of prostaglandin E1, isoproterenol, prostacyclin, and nifedipine in experimental porcine pulmonary hypertension.
    Prielipp RC, McLean R, Rosenthal MH, Pearl RG.
    Crit Care Med; 1991 Jan; 19(1):60-7. PubMed ID: 1986891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.